The official blog of the Lung Institute.

How Common is Emphysema?

23 Aug 2017
| Under Disease Education, Emphysema | Posted by | 2 Comments
How common is emphysema?

The National Emphysema Foundation estimates that 3.1 million Americans have emphysema. This progressive disease usually affects adults over the age of 45 who are long-term smokers or workers in the coal mining, iron ore mining and related industries. It is most often caused by prolonged exposure to tobacco smoke and inhaled irritants such as coal and mineral dusts. Improved safety measures implemented in the 1970’s substantially decreased the incidence of emphysema among miners, but its occurrence has spiked in recent years as a result of less stringent safety standards.

Presently, there is no cure for emphysema. Treatment plans focus on preserving lung function for as long as possible and helping patients breathe more easily. Symptoms may be unnoticeable or very subtle at the onset of emphysema, but as the disease progresses, activities as simple as getting dressed or holding a conversation may cause breathlessness and fatigue. Commonly prescribed treatments for emphysema include supplemental oxygen, inhaled corticosteroids, pulmonary rehabilitation and bronchodilators.

The Lung Institute – the first stem cell center in the world to focus exclusively on pulmonary disease – offers an alternative form of care that harnesses the natural healing abilities of the body. Autologous stem cell therapy has the potential to actually slow the progression of emphysema and reduce lung inflammation, not just mask its symptoms. In fact, more than 80 percent of patients who receive stem cell therapy at the Lung Institute for emphysema and other forms of chronic pulmonary lung disease (COPD) report an improvement in quality of life. Stem cell therapy is relatively painless and is performed on an outpatient basis, so patients can rest comfortably in their homes immediately following the procedure.

Contact the Lung Institute at (800) 729-3065 if you would like to explore alternative treatment options for your emphysema. Our devoted medical team looks forward to the opportunity to help you breathe easier.



  1. Lung Institute

    5 months ago


    We are sorry to hear about your recent diagnosis. The Lung Institute has offices in five cities in the United States.
    Tampa, Florida
    Nashville, Tennessee
    Scottsdale, Arizona
    Pittsburgh, Pennsylvania
    Dallas, Texas

    The Lung Institute aims to deliver the highest quality of care for our patients as well as continually improve our treatments for our patients. We’re happy to answer your questions about stem cell therapy, so feel free to contact us at (855) 313-1149 to speak one-on-one with a patient coordinator. We look forward to hearing from you soon.


    The Lung Institute

  2. Jean Fraser

    6 months ago

    But I am in u.k. does that stop you from helping me? i have had enthysema for about 20 years now, which was a shock as i only smoked from the age of 19 until i was 28 I am now 64 but have also been on medication for epilepsy for 62 years caused by meningitus which i have had 3 times now. the fits have stopped but short term memory has gone due to ops.

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.